Fishawack News Articles

News

Find out first what Fishawack have been up to and how we’re continuing to grow

Jenifer Kirkland joins the Fishawack Board as Chief Financial Officer

12th June 2017
The Fishawack Group of Companies is pleased to announce the appointment of Jenifer Kirkland as the Group’s Chief Financial Officer. Jenifer also joins the Fishawack Board, taking over the Chief Financial Officer role from Dominic Miller, who will assume the responsibilities of Chief Operations Officer, working closely with Oliver Dennis, Chief Executive Officer, on further agency acquisitions.

Jenifer originally qualified as a pharmacist before directing her career towards Finance. She has previously held positions at Ernst and Young, BT, Pearson, and Edif Group, and most recently was the Chief Financial Officer for Kinapse Ltd, the life sciences consultancy. Her familiarity with pharmaceutical clients as well as experience working with private equity will enable Jenifer to make an immediate contribution to the business in her new role.

“These are exciting times for the Fishawack Group as we continue to build both our global team and the breadth of services we offer our clients,” explained Oliver Dennis. “Jenifer’s experience and leadership will be invaluable to scaling up our finance function as we set out on our next phase of growth.”

“Jenifer will assume overall responsibility for Fishawack’s internal and external financial reporting,” said Dominic Miller, current Chief Financial Officer. “We’ve recently taken on investment from LDC, and having Jenifer on board will free up my time to pursue further acquisitions for the Group in the US and Europe.”

“Jenifer clicked with the current Board members as soon as we met,” added Gail Flockhart, Group Managing Director.

Jenifer Kirkland commented: “Having understood the Fishawack team’s strategy and plan to grow the Group, I am looking forward to being part of such a thriving company, contributing to the success, and meeting the teams across the offices who are making this happen.”

Fishawack recognised in UK listing for outstanding international sales growth

9th June 2017
We’re delighted to announce that the Fishawack Group was selected for inclusion in the Sunday Times HSBC International Track 200 listing, which was published with the Business section of the newspaper on Sunday 11 June. The Sunday Times HSBC International Track 200 ranks the UK’s mid-market private companies with the fastest-growing international sales, measured over their latest two years of available accounts. Fishawack entered the annual chart at no 163.

For more details of the listing, please look at the Fast Track website: www.fasttrack.co.uk

Extract reproduced with permission. Copyright The Sunday Times HSBC International Track 200.

New Fishawack investor marks start of new phase of growth

25th January 2017

The management team of the Fishawack Group, a leading medical communications group, have just completed a tertiary management buyout in a deal worth £38M. Together with LDC, the UK’s leading mid-market private equity investor, they have bought out Growth Capital Partners (GCP), providing a strong exit after their support of the Group over the last 4 years.

Fishawack is one of the largest independent global medical communications groups. With offices in the USA (Philadelphia and San Francisco), UK (Manchester, Oxford and Brighton), Switzerland (Basel) and a team in India (Hyderabad), Fishawack employs over 240 people, most of whom hold PhDs, or are pharmacists or ex-industry personnel. Working with 15 of the top 20 pharma companies as well as innovative biotech companies, Fishawack supports medical affairs and marketing teams in educating physicians about how to optimise patient outcomes.

Oliver Dennis, one of the founders of Fishawack and the Group’s Chief Executive commented, “We’re really excited about working with the team at LDC. We’ve been able to build a good relationship with them over a period of time and so we’ll hit the ground running. I can see that they share our ambition for the Group and on a personal level will be a good fit with us as a management team. We have a clear vision and a bold plan, and we have an investor that can help us to achieve them.”

LDC’s Investment Director, Simon Braham said, “We’ve provided a funding structure that will allow Fishawack management to continue their strategy of acquiring complementary businesses in the medical communications and medical marketing space. Also, Fishawack have been developing some innovative new services and forming novel partnership agreements. We want to support them in scaling these up.”

Gail Flockhart, Fishawack’s Group Managing Director, added, “This is good for clients and employees who want to work with a business that is shaping the communications industry. Fishawack will benefit from increased scale, reach, services and talent. Clients tell us that they want innovation. Innovation is part of our DNA, but it takes investment of time, money and commitment because of the lead time to drive adoption of new ideas. This investment in Fishawack will really accelerate our development.”

Garrett Curran, Managing Partner at GCP, said, “We are delighted to have worked with the Fishawack management team over the last 4 years and, after supporting three strategic acquisitions, to see the Group more than double in size. We wish the team all the best for the future as they move to the next stage of their growth strategy and build scale across the impressive international Group.”

Dominic Miller, Fishawack’s Chief Financial Officer, added his thanks to Ruth Percival at BDO for lead corporate finance advisory, and Craig Scott and Michael Murphy of Hill Dickinson LLP (Liverpool) who provided legal oversight of all aspects of the transaction. “I cannot endorse Ruth, Craig and Michael strongly enough.”